The clinical features of abetalipoproteinaemia were first described by Bassen and Kornzweig in 1950 and it is now 15 years since three independent groups showed the absence of betalipoprotein in this condition (Lamy et al., 1960; Mabry et al., 1960; Salt et al., 1960) . It has now been shown that the primary defect is failure of synthesis of apo B, which is the major apoprotein of betalipoprotein and is also essential for the formation of pre-betalipoprotein and chylomicra (Gotto et al., 1971) . The disorder usually presents in infancy with symptoms due to malabsorption of fat which can be satisfactorily treated by restriction of dietary fat (Lloyd and Muller, 1972) . In occasional patients the diagnosis has been delayed until adult life when neurological disability has generally been the presenting feature. The retinal and neurological abnormalities, which do not usually become apparent until the end of the first decade, are thought to progress to severe crippling and visual impairment and present a difficult management problem.
Although many case reports and several reviews have been published (Schwartz et al., 1963; Sobrevilla et al., 1964; Sturman, 1968; Kayden, 1972; Lloyd and Wolff, 1974) , and individual aspects of the disorder have been studied in detail, there have been few reports of the natural history in individual patients or of the long-term prognosis. This paper presents a long-term follow-up (3 -4-15 *8 years) of 8 patients.
Patients
The age at diagnosis and at follow-up, and the treatment are shown in Initially most children had lower intakes. MCT=medium-chain tryglycerides. management have been previously described (Lloyd and Muller, 1972 (Francis, 1975 (verbal) and 92 (performance) at 9 6 years. Psychological assessment indicated considerable disturbance in mother-child relationship and psychiatric help was given. Recent assessment showed some improvement and he continues to attend a normal school. Case 7 who had an IQ of 111 at the age of 5 years completed normal primary schooling, entered grammar school at 11 years, and is about to enter a college of further education. Case 8 was known to be mentally retarded with an IQ of 65 at diagnosis and required special schooling; he is now employed in an upholsteryworkshop for the disabled.
Other features. Case 7 started to have attacks of paroxysmal tachycardia (mainly after severe exertion) at the age of 13. Her cardiovascular system was examined by Dr. Clifford Parsons and no other abnormality was detected. Attacks are now infrequent, but occasionally require control with digoxin. Cases 5 and 6 have both had unusually dry skin requiring local applications of emulsifying ointment.
Discussion
There is general agreement that symptoms referable to malabsorption improve with age in patients with abetalipoproteinaemia (Fredrickson et al., 1972) , and our study shows that, with the early institution of measures to control steatorrhoea, normal physical growth potential can be achieved. By contrast the neurological and retinal lesions, which usually develop towards the middle or end of the first decade, are thought to progress and lead to severe crippling in early adult life (Sobrevilla et al., 1964; Schwartz et al., 1963; Sturman, 1968) . In our 5 youngest patients it is too early to say whether treatment has influenced this aspect as all are still under 10 years of age. In the 3 eldest, the original patient of Salt et al. (1960) has reached the age of 17 without evidence of progressive neurological disease and with only mild retinopathy which has remained unchanged since the age of 5 and does not interfere with vision. The patient of Forsyth et al. (1965) was known to have deteriorating neurological function between 7 and 10 years but since this time deterioration has halted and there has probably been improvement in both neurological and retinal function. The third patient developed minimal signs of sensory and motor nerve involvement in the legs at the age of 1 1 but is otherwise well. It is not possible to be certain whether the condition of these 3 patients compared with those reported in the literature represents variation in the natural history of the disorder, or is the result of treatment.
The pathogenesis of the neurological and retinal lesions has not yet been established. The suggestion that prolonged exposure of retinal and/or nerve cells to serum deficient in betalipoprotein may result in impairment of cell function and ultimately in degeneration (Forsyth et al., 1965) has not been substantiated or refuted. The low level of linoleic acid, shown in serum and the red cell membrane (Jones and Ways, 1967; Barnard et al., 1970 ) may contribute to abnormal neurological function but is unlikely to be the sole cause. Recent evidence relating abnormal metabolism or incorporation of linoleic acid to multiple sclerosis (Thompson, 1972) suggests that this fatty acid may be important for normal myelination. It is of interest that our 2 eldest patients have both had small supplements of polyunsaturated oil for many years and the neurological state of one (Case 7) is excellent, and in the other (Case 8) deterioration has been halted with probable improvement.
Vitamin A deficiency was originally considered to be a contributory factor in the development of the retinopathy, but Case 7 developed retinal changes at the age of 5 years despite having normal serum levels from the age of 22 months (Wolff et al., 1964) . Additional vitamin A had also been given to Case 8 for several years before diagnosis but it did not prevent the development of severe retinitis and neurological impairment at the age of 7 years, nor continued deterioration in these features (Forsyth et al., 1965) . Furthermore the rhodopsin bleaching studies in this patient attested to normal vitamin A metabolism at least in respect of the receptor cells. Reports, however, that giving vitamin A may result in an improvement in dark adaptation and the ERG response (Carr, 1970; Sperling et al., 1972) suggest that vitamin A may at least in some cases play a part in the retinal lesions and should certainly be given to all patients in doses sufficient to maintain normal serum levels.
The possibility that vitamin E deficiency might be important in the development of the neuroophthalmological features was considered because of pathological conditions caused by vitamin E deficiency in animals. Encephalomalacia with clinical signs of ataxia, spasms, or paralysis occurs in the chick (Pappenheimer and Goettsch, 1931) and impaired reproduction and muscular dystrophy have been reported in a number of species (Roels, 1967) . In the human, reduced serum levels occur in many conditions in which fat malabsorption is a feature but the most severe degree of vitamin E deficiency is found in abetalipoproteinaemia in which serum levels are undetectable and tissue levels (as judged by in vitro tests of red cell haemolysis) very low (Kayden and Silber, 1965; Muller et al., 1974) . This deficiency, probably present from birth, results from impaired absorption due to lack of chylomicron formation, and defective transport due to lack of betalipoprotein, the principal carrier protein (McCormick et al., 1960) . The condition therefore provides an ideal model for studying the effects of vitamin E deficiency in man. In previous studies we showed that sufficient vitamin E is absorbed from large oral doses, presumably via the portal vein, to correct the abnormal red cell haemolysis and to produce detectable serum levels (Muller et al., 1974) .
It may be significant that none of our patients who were given vitamin E before the age of 1 5 years (Cases 1-6) has developed retinopathy, whereas the 2 eldest children (Cases 7, 8) in whom vitamin E was not started until 8 and 10 years developed retinopathy at 5 and 7 years respectively. In the 3 eldest children (Cases 6-8), progressive neurological abnormality is absent in Case 7 now aged 17 years, is minimal in Case 6 aged 11 years, and deterioration has ceased in Case 8 aged 19 years with return of some functions to normal. It is tempting to speculate that vitamin E therapy has contributed to these results; no other major modification to the therapeutic regimen was made but possibly a synergistic effect between vitamin E and linoleic acid may be operating in the 2 oldest children. Vitamin E is thought to play an important role in maintaining the stability and integrity of biological membranes by interacting with polyunsaturated fatty acids (Diplock and Lucy, 1973) and interaction may also occur with vitamin A (Roels et al., 1965) .
Impairment of intellectual development is not a constant feature of abetalipoproteinaemia. Forsyth et al. (1965) suggested that it only occurred in children from families in which consanguinity was present and that the mental retardation might be a chance association. However, in our present series intellectual handicap is present in 3 children and in only one of the families is consanguinity present. The prognosis for intelligence should be guarded in the young child with abetalipoproteinaemia but deterioration in intellectual function need not be expected.
Cardiac abnormalities with dysrhythmia have been reported in 4 patients and were the cause of death in 3 (Fredrickson et al., 1972) . The pathogenesis is not known. In a 10-year-old boy who died suddenly 6 months after the onset of cardiac symptoms necropsy showed interstitial myocardial fibrosis and excessive lipochrome pigment in the cardiac muscle (Dische and Porro, 1970) . In Friedreich's ataxia, which has many neurological features in common with abetalipoproteinaemia, similar cardiac abnormalities often occur. In Case 7 it seems likely that the paroxysmal tachycardia is part of her disorder and not simply a chance occurrence. We thank Drs. M. Baber, C. C. Forsyth 
